Dr. Katina M. Robison

Claim this profile

Women and Infants Hospital

Studies Cancer
Studies Ovarian Cancer
13 reported clinical trials
23 drugs studied

Area of expertise

1Cancer
Katina M. Robison has run 7 trials for Cancer. Some of their research focus areas include:
Stage IV
BRCA1 positive
BRCA2 positive
2Ovarian Cancer
Katina M. Robison has run 6 trials for Ovarian Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III

Affiliated Hospitals

Image of trial facility.
Women And Infants Hospital
Image of trial facility.
Women & Infants Hospital

Clinical Trials Katina M. Robison is currently running

Image of trial facility.

Ipatasertib + Chemotherapy

for Cancer

This phase II ComboMATCH treatment trial tests the usual treatment of chemotherapy (paclitaxel) plus ipatasertib in patients with solid tumor cancers that that cannot be removed by surgery (unresectable), has spread to nearby tissue or lymph nodes (locally advanced) or from where it first started (primary site) to other places in the body (metastatic), and has an AKT genetic change. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Targeted therapy, such as Ipatasertib, may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. The addition of ipatasertib to paclitaxel in solid tumors with an AKT genetic change could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression). Researchers hope to learn if paclitaxel plus ipatasertib will shrink this type of cancer or stop its growth.
Recruiting1 award Phase 2
Image of trial facility.

Letrozole +/- Chemotherapy

for Ovarian Cancer

This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria

More about Katina M. Robison

Clinical Trial Related6 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Katina M. Robison has experience with
  • Paclitaxel
  • Letrozole
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Selinexor
  • Matching Placebo For Selinexor

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katina M. Robison specialize in?
Katina M. Robison focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Katina M. Robison currently recruiting for clinical trials?
Yes, Katina M. Robison is currently recruiting for 2 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Katina M. Robison has studied deeply?
Yes, Katina M. Robison has studied treatments such as Paclitaxel, Letrozole, Quality-of-Life Assessment.
What is the best way to schedule an appointment with Katina M. Robison?
Apply for one of the trials that Katina M. Robison is conducting.
What is the office address of Katina M. Robison?
The office of Katina M. Robison is located at: Women and Infants Hospital, Providence, Rhode Island 02905 United States. This is the address for their practice at the Women and Infants Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.